Today, the Governments of Canada and Nova Scotia signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, Member of Parliament Brendan Hanley, on behalf of the Honourable Kamal Khera, Canada’s Minister of Health, and the Honourable Tracy-Anne McPhee, Yukon’s Minister of Health and Social Services, announced the signing of a pharmacare agreement to invest up to $9.5 million over four years to provide universal access to contraceptive and diabetes medications for residents of Yukon. The funding from this agreement will also improve access to diabetes devices and supplies.
Today, the Government of Canada and the territory of Yukon signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $8.5 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, the Governments of Canada and Northwest Territories signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.8 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, the Governments of Canada and Nunavut signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.3 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable John Main, Nunavut’s Minister of Health, announced a bilateral agreement investing over $7.3 million over three years to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.
Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Lesa Semmler, Northwest Territories’ Minister of Health and Social Services, announced a bilateral agreement investing over $7.8 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.
Today, the Honourable Mark Holland, Canada’s Minister of Health and the Honourable Tracy-Anne McPhee, Yukon’s Minister of Health and Social Services, announced a bilateral agreement investing over $8.5 million over three years to improve access to selected new drugs for rare disease and to support enhanced access to existing drugs, early diagnosis and screening.
To help support the response to tobacco related harms, the Government of Canada has announced more than $11.8 million in funding for 8 community-led projects through Health Canada's Substance Use and Addictions Program (SUAP).
Today, the Governments of Canada and the province of Prince Edward Island (PEI) signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $10 million over three years to improve access to new drugs for rare diseases for PEI residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.